Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways.
published in: Cell Death and Disease
date of publication: 2013-10-24
main subject: zoledronic acid, prostate cancer, multiple myeloma
Cites articles 43
Date
Title
Article - wd:Q37577433